BioGenex

🌟 BioGenex Launches PMS2 Antibody for Enhanced Tumor Diagnosis 🌟 We're excited to introduce the PMS2 antibody, a critical tool in precise tumor diagnostics. PMS2, or Postmeiotic Segregation Increased 2, is part of a core group of DNA mismatch repair (MMR) proteins—alongside MLH1, MSH2, and MSH6—working together to detect and repair DNA replication errors, preserving genomic integrity. Gene mutations impacting the MMR system often lead to microsatellite instability (MSI), which is linked to Hereditary Non-Polyposis Colon Cancer (HNPCC) and other cancers like endometrial cancer. The resulting variations in PMS2 expression make it a valuable biomarker. The Anti-PMS2 antibody is highly recommended as part of a comprehensive panel to help differentiate gastrointestinal tract tumors, including HNPCC and associated extra-colonic cancers. BioGenex provides PMS2 antibody in both ready-to-use (RTU) and concentrated forms, within our Colorectal and Stomach Tumor Panel, suitable for both manual and automated systems. Our solutions empower pathologists and clinicians to achieve accurate, clinicopathological diagnoses, supporting drug discovery efforts and improving patient outcomes. Learn More: https://hubs.la/Q02Wgmj10 #BioGenex #CancerResearch #TumorDiagnosis #PMS2 #Pathology #PrecisionMedicine #CancerBiomarkers

🔬 Streamline Your Lab Workflows with the BioGenex EZ-Retriever® IR System! Introducing the EZ-Retriever® IR System – an advanced, microwave-based solution for nucleic acid and antigen retrieval of FFPE (formalin-fixed, paraffin-embedded) tissue sections. This cutting-edge system offers precise, temperature-controlled retrieval, enabling reliable and reproducible staining results. ✨ Why Choose EZ-Retriever® IR? Efficient dewaxing, rehydration, and antigen retrieval in one system Eliminates improper heat distribution and buffer evaporation Avoids tissue drying and boil-overs Consistent, reproducible, clean stains – validated with 600+ antibodies, ISH, and FISH probes Seamlessly enhance IHC, ISH, and FISH detection quality with our system, which integrates perfectly with BioGenex’s Elegance AR solutions. Boost your lab’s efficiency with consistent and reliable results every time! 🔬 #BioGenex #EZRetrieverIR #PathologySolutions #AntigenRetrieval #LaboratoryExcellence #MicrowaveRetrieval #IHC #ISH #FISH #PathologyLab

🔬 BioGenex Introduces Anti-TMPRSS2 Antibody: A Powerful Biomarker for Prostate Tumor Diagnosis 🔍 We are excited to present the Anti-TMPRSS2 antibody, a promising tool for the detection and management of prostate cancer. TMPRSS2 (Transmembrane Protease, Serine 2), also known as PRSS10, is a type II transmembrane multimeric serine protease regulated by androgens and expressed on the surface of prostate cells. This critical biomarker is associated with immune infiltration, tumor growth, and metastasis in prostate cancer, making it a key player in advancing diagnostic capabilities. 🧬 🔎 Why TMPRSS2 Matters: TMPRSS2 is over-expressed in a significant proportion of prostate cancer cases, highlighting its potential as a target for both diagnosis and treatment. Leveraging the Anti-TMPRSS2 antibody can help clinicians achieve precise, reproducible results with clean, crisp, and intense staining quality—leading to more informed treatment strategies and improved patient outcomes. ⚙️ BioGenex Solutions: Our Anti-TMPRSS2 antibody is available in ready-to-use (RTU) and concentrated formats for both manual and automated systems, setting a new standard in clinicopathological diagnostics and drug discovery. BioGenex ensures that pathologists and clinicians can make accurate diagnoses, ultimately improving life expectancy for prostate cancer patients. 👉 Learn more about how BioGenex is transforming prostate cancer diagnosis: [https://hubs.la/Q02VPl2H0] #ProstateCancer #CancerDiagnosis #TMPRSS2 #BioGenex #Pathology #CancerResearch #Biomarkers #Immunohistochemistry #DrugDiscovery #HealthcareInnovation #Oncology

🔬 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐍𝐞𝐰𝐬 𝐟𝐨𝐫 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐛𝐬! 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐗𝐦𝐚𝐭𝐫𝐱® 𝐈𝐧𝐟𝐢𝐧𝐢𝐭𝐲 Are you ready to revolutionize your Cellular & Molecular Pathology Lab? We're thrilled to introduce Xmatrx® Infinity, the most advanced and fully automated system designed to supercharge your life sciences research, drug discovery, and development processes. 🚀 𝐊𝐞𝐲 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐬 & 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬: 🌟 Fully Automated: Streamline your lab with 40 simultaneous assays. 🧪 Multi-Format Compatibility: Works with various specimen types. 🌡️ Precise and Consistent: eXACT™ Temperature Control, precise dispensing. 🌐 Open System: Adaptable to any slide-based staining assay. 💲 Cost-Efficient: Minimal reagent usage (as low as 10µL). Ready to revolutionize your lab? Learn More: https://hubs.la/Q02Vg_Yx0 #PathologyLab #labautomation #XmatrxInfinity

🔬 Understanding B-Cell Malignancies with BOB1 🔬 B-cell-specific Octamer Binding protein-1 (BOB1) plays a critical role as a co-activator of OCT-2 and is essential for antigen-dependent germinal center formation. BOB1 is an invaluable tool in differentiating malignancies of B cell origin, particularly in diagnosing B-cell lymphoma. 💡 Why BOB1 Matters: Dysregulated BOB1 expression contributes to the development of B-cell lymphoma. Lack of BOB1 expression helps distinguish between lymphocyte predominance Hodgkin lymphoma (LPHL) and classic Hodgkin lymphoma (CHL). Strong association with Epstein-Barr virus (EBV) positivity enhances diagnostic accuracy. At BioGenex, we offer ready-to-use (RTU) and concentrated forms of BOB1 antibodies for both manual and automated systems, providing pathologists and clinicians with the precision they need for clinicopathological diagnosis and drug discovery. 🔗 Learn more about our best-in-class solutions: BioGenex #BCellLymphoma #BOB1Antibody #CancerDiagnostics #PathologySolutions #BioGenex #Immunohistochemistry #CancerResearch

🌸 October is Breast Cancer Awareness Month 🌸 At BioGenex, we are proud to support the fight against breast cancer with our comprehensive panel of Breast Cancer Antibodies. These high-quality antibodies are designed to enhance diagnostic accuracy and help medical professionals detect and treat breast cancer earlier and more effectively. 🔬 Our Breast Cancer Antibodies include: Estrogen Receptor (ER) Progesterone Receptor (PR) HER2/neu Ki-67 p53 And more! With the right tools, we can make a difference in the early detection and treatment of breast cancer. Let’s work together to save lives. 🌟 Visit BioGenex to learn more about our Breast Cancer Antibodies panel. #BreastCancerAwareness #BreastCancerResearch #PathologySolutions #CancerDiagnostics #BioGenex #Immunohistochemistry #CancerAntibodies

Boost your pathology lab's capabilities with BioGenex i6000™ Diagnostics! 𝑯𝒆𝒓𝒆 𝒂𝒓𝒆 𝒔𝒐𝒎𝒆 𝒌𝒆𝒚 𝒇𝒆𝒂𝒕𝒖𝒓𝒆𝒔 𝒂𝒏𝒅 𝒃𝒆𝒏𝒆𝒇𝒊𝒕𝒔: 𝐇𝐢𝐠𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭: Process up to 200 slides in an 8-hour shift, enhancing productivity. 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐲𝐩𝐞𝐬: From frozen to formalin-fixed paraffin-embedded (FFPE) samples, cell preparations, and smears, it handles them all. 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐞𝐝 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬: Over 600 pre-optimized staining protocols ensure consistent and reliable results. 𝐏𝐫𝐞𝐜𝐢𝐬𝐞 𝐑𝐞𝐚𝐠𝐞𝐧𝐭 𝐃𝐢𝐬𝐩𝐞𝐧𝐬𝐢𝐧𝐠: Minimize wastage with dispensing as low as 100 µL per slide, ensuring cost-effectiveness. 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰: Streamline processes with minimal hands-on time, improving overall efficiency. 𝐀𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐑𝐞𝐚𝐠𝐞𝐧𝐭 𝐇𝐚𝐧𝐝𝐥𝐢𝐧𝐠: Liquid level sensor ensures precise management, reducing errors. 𝐓𝐡𝐢𝐫𝐝-𝐏𝐚𝐫𝐭𝐲 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐢𝐞𝐬 𝐂𝐨𝐦𝐩𝐚𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲: Flexibility in staining options with compatibility for third-party antibodies. 𝐒𝐩𝐚𝐜𝐞-𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐃𝐞𝐬𝐢𝐠𝐧: Occupies about 70% less space compared to other systems, without compromising throughput. 𝐁𝐚𝐫𝐜𝐨𝐝𝐞𝐝 𝐑𝐞𝐚𝐠𝐞𝐧𝐭 𝐕𝐢𝐚𝐥𝐬: Simplify workflow with ready-to-use barcoded vials, minimizing technician time. 𝐒𝐞𝐚𝐦𝐥𝐞𝐬𝐬 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧: Works seamlessly with EZ–Retriever® IR System and i500 barcode printer for efficient de-waxing, rehydration, and antigen retrieval. Unlock the potential of your pathology lab with BioGenex i6000™ Diagnostics. Contact us for more information!" Learn more: https://hubs.la/Q02RD9Bw0

🌟 Event Glimpse: NIH Fall Research Festival 2024 🌟 (September 25th, Bethesda, MD) We were thrilled to participate in the NIH Fall Research Festival 2024! 🚀 As a proud subsidiary of BioGenex, Omicsveu continues to push the boundaries of Spatial Biology research with our cutting-edge, fully automated NanoVIP® systems. From ImmunoPlex to eFISH, miRFISH, Genotyping & Phenotyping, and In situ Sequencing, we are committed to making advanced research accessible and simplified through automation. Our team had an amazing time connecting with fellow researchers and discussing the future of Spatial Biology. If you attended the event, we’d love to keep the conversation going! Let's collaborate on driving innovation forward. 💡 Learn More: https://hubs.la/Q02RbmXM0 #NIHResearchFestival #SpatialBiology #NanoVIP #Biotechnology #Innovation #Automation #ScientificResearch #Omicsveu #BioGenex #InSituSequencing #ResearchAndDevelopment #Genotyping #Phenotyping

🌟 Highlights from the 7th Annual Conference of the Indian Association of Pathologists & Microbiologists (Telangana State Chapter) 2024! 🌟 On September 14-15, we joined leading experts at Osmania Medical College, Hyderabad, for insightful discussions on the latest advancements in pathology and microbiology. Key moments included: Engaging keynote speeches Interactive panels Valuable networking opportunities Thank you to the organizers and participants for an inspiring event! Excited to implement our learnings and look forward to the next edition! 💡🔬 #IAPM2024 #Pathology #Microbiology #Networking #Innovation

🔬 Understanding ATRX in Cancer Research 🧬 ATRX, a key player in chromatin remodeling and transcription regulation, is crucial in cancer biology. Loss of ATRX protein, especially in breast cancer, is linked to lymphatic invasion and telomere maintenance independent of telomerase. BioGenex offers top-tier RTU & concentrated antibodies for precise clinicopathological diagnosis and drug discovery, helping clinicians improve patient outcomes. Learn More: https://hubs.la/Q02MGN280 #CancerResearch #ATRX #Diagnostics #BioGenex #HealthcareInnovation #Oncology